| scholarly article | Q13442814 |
| P50 | author | Gerardo Gamba | Q42324007 |
| P2093 | author name string | Norma A Bobadilla | |
| Joseph V Bonventre | |||
| Vishal S Vaidya | |||
| Cristino Cruz | |||
| Joyce Trujillo | |||
| Norma Uribe | |||
| Jazmin Pérez-Rojas | |||
| Jorge A Blanco | |||
| P2860 | cites work | Spironolactone improves angiotensin-induced vascular changes and oxidative stress | Q44167932 |
| Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity. | Q44242743 | ||
| Effectiveness of aldosterone blockade in patients with diabetic nephropathy | Q44269017 | ||
| Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury | Q44643853 | ||
| Mycophenolate mofetil ameliorates arteriolopathy and decreases transforming growth factor-beta1 in chronic cyclosporine nephrotoxicity | Q44663035 | ||
| The natural history of chronic allograft nephropathy | Q44688416 | ||
| Effect of aldosterone on renal transforming growth factor-beta | Q44886467 | ||
| Prevention of renal fibrosis by spironolactone in mice with complete unilateral ureteral obstruction | Q45062038 | ||
| Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease | Q45251122 | ||
| Effect of pirfenidone on apoptosis-regulatory genes in chronic cyclosporine nephrotoxicity | Q45281302 | ||
| Aldosterone induces myocyte apoptosis in the heart and skeletal muscles of rats in vivo | Q46502212 | ||
| A role for mineralocorticoid receptor blockade in the prevention of apoptosis | Q46566685 | ||
| Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study. | Q46571307 | ||
| Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. | Q46713499 | ||
| Regression of existing glomerulosclerosis by inhibition of aldosterone | Q46726706 | ||
| Protective effect of spironolactone on endothelial cell apoptosis. | Q46960471 | ||
| Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury | Q48039370 | ||
| Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats | Q48546780 | ||
| Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. | Q51034359 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration | Q28215816 | ||
| The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators | Q28372091 | ||
| Renocortical mRNA expression of vasoactive factors during spironolactone protective effect in chronic cyclosporine nephrotoxicity | Q28564455 | ||
| Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury | Q32073071 | ||
| Aldosterone directly induces myocyte apoptosis through calcineurin-dependent pathways. | Q33204659 | ||
| Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction | Q34187441 | ||
| Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma | Q34195728 | ||
| CLINICAL CHARACTERISTICS OF PRIMARY ALDOSTERONISM FROM AN ANALYSIS OF 145 CASES. | Q35417596 | ||
| Aldosterone target organ protection by eplerenone | Q35769004 | ||
| Aldosterone in the development and progression of renal injury | Q35807297 | ||
| Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure | Q36314459 | ||
| Role of aldosterone in the remnant kidney model in the rat. | Q37358980 | ||
| Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity. | Q44039596 | ||
| Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy | Q44145091 | ||
| P433 | issue | 1 | |
| P921 | main subject | cyclosporine | Q367700 |
| P304 | page(s) | F131-9 | |
| P577 | publication date | 2006-07-11 | |
| P1433 | published in | American Journal of Physiology - Renal Physiology | Q2610177 |
| P1476 | title | Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity. | |
| P478 | volume | 292 |
| Q37331901 | A rapid urine test for early detection of kidney injury. |
| Q57275226 | AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease |
| Q43298131 | Adrenalectomy prevents renal ischemia-reperfusion injury |
| Q46681454 | Aldosterone and TGF-beta1 synergistically increase PAI-1 and decrease matrix degradation in rat renal mesangial and fibroblast cells |
| Q36807031 | Aldosterone induces mesangial cell apoptosis both in vivo and in vitro |
| Q53565738 | Aldosterone promotes proximal tubular cell apoptosis: role of oxidative stress. |
| Q43191091 | Aldosterone-induced TGF-beta1 expression is regulated by mitogen-activated protein kinases and activator protein-1 in mesangial cells |
| Q36878533 | An additive effect of eplerenone to ACE inhibitor on slowing the progression of diabetic nephropathy in the db/db mice |
| Q38003686 | Are recently reported biomarkers helpful for early and accurate diagnosis of acute kidney injury? |
| Q34727374 | Bilirubin attenuates the renal tubular injury by inhibition of oxidative stress and apoptosis |
| Q34814081 | Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptions |
| Q35880139 | Cell adhesion molecules in chemically-induced renal injury |
| Q37128891 | Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis. |
| Q37348057 | Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium |
| Q47107775 | Does Mineralocorticoid Receptor Antagonism Prevent Calcineurin Inhibitor-Induced Nephrotoxicity? |
| Q42773419 | Effects of spironolactone and losartan on diabetic nephropathy in a type 2 diabetic rat model |
| Q26829452 | Emerging biomarkers and metabolomics for assessing toxic nephropathy and acute kidney injury (AKI) in neonatology |
| Q28571354 | Expression of kidney injury molecule-1 (Kim-1) in relation to necrosis and apoptosis during the early stages of Cd-induced proximal tubule injury |
| Q37764468 | Hypertension in the kidney transplant recipient. |
| Q28570560 | Increased susceptibility of aging kidney to ischemic injury: identification of candidate genes changed during aging, but corrected by caloric restriction |
| Q43417115 | Inhibition of mineralocorticoid receptors with eplerenone alleviates short-term cyclosporin A nephrotoxicity in conscious rats |
| Q34043503 | KAP degradation by calpain is associated with CK2 phosphorylation and provides a novel mechanism for cyclosporine A-induced proximal tubule injury |
| Q43758780 | KIM-1 expression in kidney allograft biopsies: Improving the gold standard |
| Q37196891 | Kidney Injury Molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury |
| Q51752551 | Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. |
| Q34042098 | Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury |
| Q37355170 | Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity |
| Q33913977 | Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. |
| Q38072247 | Mechanisms of cyclosporine-induced renal cell apoptosis: a systematic review |
| Q37853831 | Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease. |
| Q36788871 | New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone. |
| Q37259371 | Preclinical evaluation of novel urinary biomarkers of cadmium nephrotoxicity |
| Q46790238 | Quantitative analyses of kidney injury molecule-1 messenger RNA in kidney transplant recipients with graft dysfunction. |
| Q40188939 | Randomized Controlled Trial of Mineralocorticoid Receptor Blockade in Children with Chronic Kidney Allograft Nephropathy |
| Q33754669 | Renal aspirin: will all patients with chronic kidney disease one day take spironolactone? |
| Q57275237 | Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone |
| Q28567114 | Renoprotective mechanisms of soy protein intake in the obese Zucker rat |
| Q53357907 | Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification. |
| Q46108426 | Spironolactone ameliorates transplant vasculopathy in renal chronic transplant dysfunction in rats |
| Q45818886 | Spironolactone inhibits apoptosis in rat mesangial cells under hyperglycaemic conditions via the Wnt signalling pathway |
| Q46394125 | Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury |
| Q55280810 | The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity: a multicenter randomized, double-blind, clinical trial (the SPIREN trial). |
| Q34593274 | The mineralocorticoid receptor antagonist eplerenone reduces renal interstitial fibrosis after long-term cyclosporine treatment in rat: antagonizing cyclosporine nephrotoxicity |
| Q33828918 | Urinary chemokine (C-C motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity |
Search more.